J&J gets FDA approval for therapy to treat blood cancer
J &J gets approval from FDA for medicine to treat a type of blood cancer-Multiple Myeloma
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
J &J gets approval from FDA for medicine to treat a type of blood cancer-Multiple Myeloma
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.
Pfizer set to increase Covid-19 vaccine prices by almost four times in the US
HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of.
October 22, 2022: Walmart has agreed to pay Florida $215 million to settle claims that its pharmacies aided an opioid crisis in the.
Phase 3 trial for irregular heartbeat or PSVT shows good results
HQ Team October 21, 2022: Canada has recalled more than a million units of dry shampoo products of London-based Unilever after detecting a.
Lupin buys two inhalation brands for $75million
HQ Team October 19, 2022: In another eight years, about 500 million people globally will develop a spate of non-communicable diseases due to.
HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE.